Substance Use in Pregnancy:SBIRT

Substance Use in Pregnancy:SBIRT

IDENTIFICATION AND BRIEF INTERVENTION FOR SUBSTANCE USE DISORDERS IN PREGNANCY Jaye M Shyken, MD St. Louis University School of Medicine October 4, 2018 OBJECTIVES Understand Understand the epidemiology of substance use in pregnancy

Screen How to screen for Substance Use in pregnancy Counsel about Be Be aware of the counseling about the impact of substance use

on the fetus/neonate Be able to refer patients with known or suspected substance use for counseling and follow-up Know about Know about current legislation as it relates to

substance use in pregnancy in MO and IL IMPORTANT CONCEPTS Drug addiction is a disease Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry. Dysfunction in these circuits leads to characteristic biological, psychological, social and spiritual manifestations. This is reflected in an individual pathologically pursuing reward and/or relief by substance use and other behaviors. Addiction is characterized by inability to consistently abstain, impairment in behavioral control, craving, diminished recognition of significant problems with ones behaviors and interpersonal relationships, and a dysfunctional emotional response. Like other chronic diseases, addiction often involves cycles of relapse and remission. Without treatment or engagement in recovery activities, addiction is progressive and can result in disability or premature death.

Not a character flaw IMPORTANT CONCEPTS RISK FACTORS FOR ADDICTION Addiction is not inevitable depends on a number of factors Genetic Biological factors Age at first use Psychological (personality) Environmental factors (availability, family and peer dynamics, financial resources, cultural norms, stress, access to social support) Higher risk Co-occurring mental health problems Genetic and molecular factors

Early life adverse events Drug misuse in adolescence FFR1.11 NUMBERS OF PAST MONTH ILLICIT DRUG USERS AMONG PEOPLE AGED 12 OR OLDER: 2017 Note: Estimated numbers of people refer to people aged 12 or older in the civilian, noninstitutionalized population in the United States. The numbers do not sum to the total population of the United States because the population for NSDUH does not include people aged 11 years or younger, people with no fixed household address (e.g., homeless or transient people not in shelters), active-duty military personnel, and residents of institutional group quarters, such as correctional facilities, nursing homes, mental institutions, and long-term care hospitals. Note: The estimated numbers of current users of different illicit drugs are not mutually exclusive because people could have used or misused more than one type of illicit drug in the past month. NATIONAL SURVEY OF DRUG USE AND

HEALTH (NSDUH) 2012-2013 PAST MONTH USE, WOMEN 15-44 Pregnant Nonpregnant 5.4% 11.4% Tobacco 15.4% 24.0%

Alcohol 9.4% 55.4% Binge Drinking 2.3% 24.6% Illicit Drugs MJ, Cocaine, Heroin, Halucinogens, inhalants, nonmedical use of pain relievers,

tranquilizers, stimulants, sedatives http://www.oas.samhsa.gov/nhsda.htm PREVALENCE OF MARIJUANA USE NATIONAL SURVEY OF DRUG USE AND HEALTH, 2007-2012 Ko JY, Farr SL, Rong VT, et al. Am J Obstet Gynecol 213;201.e1-201.e10 (Aug 2015) PRESCRIPTION OPIOIDS: 1999-2010 80% of the worlds oral opioids are used

in the US CDC, MWWR 2011 HEROIN USE: 2002-2013 80% of heroin users initially used Rx opioids TRENDS IN HEROIN USE AND HEROIN DEATHS www.cdc.gov/vitalsigns/heroin/infographic.html#graphic, 2016 64,400 overdose

deaths in 2016 42,249 with any opioid 15,469 with heroin 33,900 with natural and synthetic opioids (except methadone) OPIOID USE DISORDER AT DELIVERY, 1999-2014 Haight SC, Ko JY, et al. MMWR August 10, 2018;67(31);845-9 2016 MO MEDICAID CLAIMS DATA FOR SUBSTANCE USE IN PREGNANCY, SUMMARY COUNTS

Counts Total pregnant women Alcohol Use Disorder Cannabis Use Disorder % of Total Pregnant 60,310 100 537 0.89 1418

2.35% Opioid dependence 990 1.64% Opioid Use Disorder 945 1.57% Other Substance Use Disorders

1732 2.87% Any Substance Use Disorder 3707 6.15% Any SUD, not OUD in same year 2223 3.69%

Any Opioid Use Disorder 1484 2.4% Report Prepared by MO Dept Social Services, MO Healthnet Division, 2017 PATTERNS OF DRUG USE Use Sporadic consumption with no apparent consequences Misuse Sporadic or more frequent use, some consequences experienced by user Physical dependence

Drug class-specific withdrawal syndrome produced by abrupt cessation or rapid dose reduction or by administration of an antagonist Psychological dependence Subjective sense of need, for positive effects or to avoid negative effects of abstinence Addiction Primary, chronic, neurobiologic disease. Characterized by impaired control over drug use, compulsive use, continued use despite harm, and craving FFR1.65 RECEIVED SPECIALTY SUBSTANCE USE TREATMENT IN THE PAST YEAR AMONG PEOPLE AGED 12 OR OLDER WHO NEEDED SUBSTANCE USE TREATMENT IN THE PAST YEAR, BY AGE GROUP: 2017 https://www.samhsa.gov/data/report/slides-2017-nsduh-annual-national-

FFR1.66 PERCEIVED NEED FOR SUBSTANCE USE TREATMENT AMONG PEOPLE AGED 12 OR OLDER WHO NEEDED BUT DID NOT RECEIVE SPECIALTY SUBSTANCE USE TREATMENT IN THE PAST YEAR: 2017 https://www.samhsa.gov/data/report/slides-2017-nsduh-annual-nationalreport FFR1.67 REASONS FOR NOT RECEIVING SUBSTANCE USE TREATMENT IN THE PAST YEAR AMONG PEOPLE AGED 12 OR OLDER WHO FELT THEY NEEDED TREATMENT IN THE PAST YEAR: PERCENTAGES, 2017 https://www.samhsa.gov/data/report/slides-2017-nsduh-annual-national-report

Note: Respondents could indicate multiple reasons for not receiving substance use treatment; thus, these response categories are not mutually exclusive. SBIRT Screening, Brief Intervention, and Referral for Treatment SCREENING ASSESSES SUBSTANCE USE AND SEVERITY Chemical Screening Screening Tools URINE TESTING FOR DRUGS OF ABUSE

Drug Duration in Urine False positives Amphetamines Methamphetamin e 2-3 d 3-6 d Ephedrine, pseudoephedrine, phenylephrine, chlorpromazine, bupropion, amantadine, ranitidine, metformin, labetalol

Barbiturates 2-4 d Ibuprofen, naproxen Benzodiazepines Depends, 2 d to 6 wks Sertraline Cannabinoids

1-7d episodic 21-30 d chronic Ibuprofen, naproxen, efavirenz, hemp seed oil Cocaine 2-3 d Topical anesthetics containing cocaine Methadone 3-4 d Doxylamine, diphenhydramine, quetiapine

Opiates 1-3 d Rifampin, fluoroquinolones, poppy seeds, quinine (tonic water), doxylamine Phencyclidine 7-14 d Ketamine, dextromethorphan, diphenhydramine The Medical Letter 2002;44:71-7 NEONATAL URINE TESTING

FOR DRUGS OF ABUSE Drug Duration in Urine Amphetamines Methamphetamine 1-2d 1-2 d Barbiturates 2-6 weeks Benzodiazepines

Moderate: 3 to 5 days Heavy: 3 to 6 weeks Cannabinoids One joint: 2 d 3 times per week: 2 weeks Daily: 3 to 6 weeks Cocaine 2-4 d Methadone

2-3 d Opiates 1-2 d Phencyclidine 2-8 d Moses S. Toxicology Screening, Urine Tox Screen. Family Practice Notebook; 2005 www.fpnotebook.com/Psych/Lab/TxclgyScrng.htm TESTING OF MECONIUM AND UMBILICAL CORD TISSUE Meconium

Reflects drug exposure over the last trimester in term infant If specimen tests positive, reflex to confirmation with mass spectrometry Umbilical cord tissue Reflects drug exposure over approximately last trimester in term infant Qualitative detection by mass spectrometry https://arupconsult.com/content/newborn-drugtesting URINE DRUG SCREENING BY RISK FACTORS Obstetric History No or scant prenatal care (< 3 visits) Preterm labor, preterm delivery, premature rupture of the membranes

Placental abruption Unexplained fetal demise Unexplained elevated blood pressure AAP and ACOG (2017) Guidelines for Perinatal Care ACOG Committee Opinion #422, updated Apr 2012 Chasnoff IJ, Neuman K, Thornton C, et al. Am J Obstet Gynecol 2001;184:752-8. URINE DRUG SCREENING BY RISK FACTORS: MEDICAL HISTORY Sexually transmitted infections HIV/AIDS Multiple STIs with current pregnancy Hepatitis Gum or periodontal disease Significant weight loss, low BMI,

malnutrition Substance misuse history History of drug use in the past two years Positive drug screen in current pregnancy Enrolled in chemical dependency treatment (including methadone) Sexual abuse Psychiatric symptoms such as anxiety, panic, hallucinations and psychosis Skin abscesses Myocardial infarction without known etiology

Cerebrovascular accident without known AAP and ACOG (2017) Guidelines for Perinatal Care ACOG Committee Opinion #422, updated Apr 2012 Chasnoff IJ, Neuman K, Thornton C, et al. Am J Obstet Gynecol 2001;184:752-8. PREVALENCE OF DRUG USE BY UNIVERSAL MATERNAL DRUG TESTING AT DELIVERY: PERFORMANCE OF SCREENING BASED ON RISK FACTORS Wexelblatt, SL, et al. J Pediatr 2015;166:5826. WHY YOU SHOULD ASK

Begins the conversation May identify drug use short of addiction Allows an opportunity for intervention or to congratulate healthy behaviors May make speaking about it in the future easier BRIEF SCREENING TOOLS NIDA Quick Screen Validated for pregnancy SURP-P CRAFFT WIDUS 5 Ps Missouri State Forms

***** PRINCIPLES OF SCREENING Ask everyone! (It is the standard of care that we ask all women about their history of medication, alcohol and tobacco use. We ask these questions of everyone.) Ask in private Non-judgmental Open-ended questions PERINATAL RISK ASSESSMENT FOR SUBSTANCE USE FORM https://health.mo.gov/living/wellness/ tobacco/atod/pdf/MCFH-4.pdf

PERINATAL RISK ASSESSMENT FOR SUBSTANCE USE FORM: TOBACCO https://health.mo.gov/living/wellness/tobacco/atod/pdf/MCFH-4.pdf PERINATAL RISK ASSESSMENT FOR SUBSTANCE USE FORM: ALCOHOL https://health.mo.gov/living/wellness/ tobacco/atod/pdf/MCFH-4.pdf PERINATAL RISK ASSESSMENT FOR SUBSTANCE USE FORM: OTHER DRUGS https://health.mo.gov/living/wellness/tobacco/atod/pdf/ MCFH-4.pdf

Wright TE, Terplan M, Ondersma SJ, et al. Am J Obstet Gynecol 2016;215;539-47 CRITERIA FOR DIAGNOSING SUBSTANCE USE DISORDERS: DSM V Increasing tolerance Withdrawal symptoms Using larger amounts or for longer than intended Wanting to cut down or stop, but not managing to Spending a lot of time to get, use or recover from drug use Craving Inability to manage commitments due to drug use < 2 = no disorder 2-3 = mild disorder

4-5 = moderate disorder > 6 = severe disorder Continuing to use, even when it causes problems in relationships Giving up important activities because of drug use Continuing to use, even in dangerous situations Continuing to use, even when physical or psychological problems may be made worse by drug use BRIEF INTERVENTION Increase intrinsic motivation to affect behavioral change (reduce or stop drug use) BRIEF INTERVENTION

1-5 patient-centered counseling sessions Lasting < 15 minutes Uses principles of motivational interviewing Wright TE, Terplan M, Ondersma SJ, et al. Am J Obstet Gynecol 2016;215;539-47 COMPLICATIONS FROM SUBSTANCE USE IN PREGNANCY Pregnancy Neonatal Cocaine Abruption, LBW, stillbirth,

PTD, SGA, hypertension (mimicking preeclampsia) Increased sensitivity to CV toxicity State dysregulation, neonatal tremors, high-pitch cry, irritability, excess suck, hyperalert, abnormal MRI, transient abnormal EEG (Toxidrome) Long term outcome likely minimal effect except, possible attention and agression Amphetamine s SGA, LBW, ?hypertension, PTD, abruption

Neurobehavioral abnormalities (attention, verbal and spatial memory,) Higher neonatal mortality Marijuana Small decrease in BW (100 Neurobehavioral effects (attention, visual problem g) solving) ?Association with small ? Effect of confounders risk of stillbirth (could not be adjusted for tobacco) LBW when smoke > 1x/wk

ACOG Committee Opinion #479, March 2011, reaffirmed 2017 ACOG Committee Opinion #722, October 2017 Conner SN, Bedell V, Lipsey K, et al. Obstet Gynecol 2016;128:713-23 Gouin K, Murphy K, Shah PS, et al. Am J Obstet Gynecol 2011;204:340.e1-12 COMPLICATIONS FROM SUBSTANCE USE IN PREGNANCY Pregnancy Neonatal Opioids (untreated heroin) IUGR, NAS abruption, fetal death, preterm

labor, meconium Tobacco Miscarriage, stillbirth (doserelated), PPROM, LBW, abruption, placenta previa, Increased irritability and hypertonicity, SIDS, asthma Benzodiazepine Withdrawal s Withdrawal

Alcohol Neurobehavioral impairment, hyperactivity, inattention, learning disability, seizures, deficits in memory and reasoning, poor executive function, poor school performance, conduct disorder, postnatal growth delay FASD, teratogenic, characteristic facial features, LBW, growth restriction, cardiac, skeletal, renal ocular anomalies

ACOG Committee Opinion #711, August 2017 Partnode CD, Henderson JT, Thompson JH, et al. Ann Intern Med 2015;163:608-21 Pruett D, Waterman EH, Caugher AB. Obstt Gynecol Surv 2013;68:62-9 NUTRITIONAL CONCERNS FOR SUBSTANCE USE IN PREGNANCY Active addiction associated with poor quality diet BMI Vitamin deficiency (thiamine, vitamin D, B12, folic acid) Iron deficiency Dental issues Inflammatory state (immune function) Recovery Weight gain and obesity Persistent of poor eating habits

REFERRAL FOR TREATMENT Provide to those identified to be at high risk (SUD) who are in need of specialty addiction care REFERRAL FOR TREATMENT Behavioral therapy (chemical

dependency treatment) MAT (now MT for OUD) Buprenorphine Methadone BEHAVIORAL INTERVENTIONS FOR SUD Contingency management (CM). Systematically use reinforcement techniques, usually monetary vouchers Originally use for cocaine. Now for opioids, MJ, tobacco, alcohol, benzodiazepines, other Motivational Interviewing (MI) Patient-centered, collaborative, highly empathic counseling style to elicit behavior change Helps patients explore and resolve ambivalence

Cognitive Behavioral Therapy (CBT) Strategies to help patients understand situations that bring about undesirable thoughts, feelings or behaviors (to then avoid when possible) Goal to break old patterns and replace with new ones Forray A. F1000Res. 2016;5:F1000 Faculty Rev887 RESOURCES SAMHSA (Substance Abuse and Mental Health Services Administration) Treatment Finder Buprenorphine provider locator https:// www.samhsa.gov/medication-assisted-treatment/physician-program-data/tre atment-physician-locator Missouri state resource

800-TEL-LINK (800 835-5465) RESOURCES Key screening conclusion by expert group Screening for substance use should be done on all pregnant women at first prenatal visit and subsequently throughout pregnancy for those at high risk Screening can be done using a validated instrument with follow-up by provider or by asking standardized questions during interview Nonjudgmental Open-ended questions Urine toxicology should not be used in place of substance use screening questions Wright TE, Terplan M, Ondersma SJ, et al. Am J Obstet Gynecol

2016;215;539-47 Counsel pregnant women about the adverse effects of tobacco, alcohol and drugs REQUIREMENTS OF SB 190 (IMPLEMENTED JULY 1992) Identify pregnancies at risk, provided for prevalence studies Inform pregnant women of addiction services Offer referrals to DHSS for service coordination Immunity from civil liability for clinicians who comply with the requirements of SB 190

HOW MISSOURI/ILLINOIS HANDLES DRUG USE DURING PREGNANCY Missouri Illinois Substance use in pregnancy is a crime No No Prosecutions for drug use during pregnancy Yes

Yes No specific law* Yes No No No specific law Yes

No No Targeted program created Yes* Yes* Pregnant women given priority access for drug treatment Yes Yes

Pregnant women protected from discrimination in publicly funded programs Yes Yes Substance use in pregnancy is child abuse Substance use in pregnancy grounds for civil commitment Health care workers must report drug use during pregnancy Testing required if drug use during pregnancy is suspected Published on Guttmacher Institute ( https://www.Guttmacher.org) Date: 01-Sep2018

QUESTIONS?

Recently Viewed Presentations

  • Colonial America SS2H3: Explain the factors that shaped

    Colonial America SS2H3: Explain the factors that shaped

    How were the New England, Mid-Atlantic, and Southern Colonies founded? What is the relationship between the 3 colonial regions? Can you describe colonial life in America from the perspective of various people? How? How did the geography of the colonies...
  • Sickle Cell Test - الصفحات الشخصية

    Sickle Cell Test - الصفحات الشخصية

    Also, sickled blood cells can become trapped in blood vessels reducing or blocking blood flow. This can damage organs, muscles, and bones and may lead to life-threatening conditions. Sickle cell test: A sickle cell test is a blood test done...
  • Sulfines &amp; Sulfenes

    Sulfines & Sulfenes

    Acid-base reaction between racemic drug and a single enantiomer compound called the resolving agent to produce diastereomers. Common acid resolving agents: Cinchona alkaloids, basic amino acids, amino alcohols, etc. Common base resolving agents: Acids (camphorsulfonic acid, tartaric acid, malic acid,...
  • Priming Your Revenue Cycle Background for Success

    Priming Your Revenue Cycle Background for Success

    Revenue cycle leaders play in important role in connecting financial data with clinical data, with the goal of improving the overall value delivered to patients and the community. The challenges revenue cycle leaders face are as difficult as they have...
  • Weds. 2/1 English 8 SLIDES ARE POSTED ON

    Weds. 2/1 English 8 SLIDES ARE POSTED ON

    Wolf: (singular); wolves, (plural) Plot: (literary), what happens in a story, in order. Values: (morality), how to live right; good behavior v. bad behavior . Today we start a very famous beast fable about a boy adopted by wolves in...
  • Organizaciones de Apoyo a los migrantes en Estados Unidos

    Organizaciones de Apoyo a los migrantes en Estados Unidos

    Arial Times New Roman Verdana Wingdings Century Gothic Symbol Eclipse Organizaciones de Apoyo a los migrantes en Estados Unidos ASOCIACIÓN MUNDIAL DE MEXICANOS EN EL EXTERIOR (AMME) COALICIÓN NACIONAL POR LA DIGNIDAD Y LA AMNISTÍA DE LOS INMIGRANTES INDOCUMENTADOS MEXICO-US...
  • Big Data Analytics over Encrypted Datasets with Seabed

    Big Data Analytics over Encrypted Datasets with Seabed

    Big Data Analytics over Encrypted Datasets with Seabed . AntonisPapadimitriou , RanjitaBhagwan , NishanthChandran , Ramachandran Ramjee , Andreas Haeberlen , HarmeetSingh , Abhishek Modi , SaikrishnaBadrinarayanan University of Pennsylvania, Microsoft Research India, UCLA ...
  • Unit 4 Response - Ohio Emergency Management Agency

    Unit 4 Response - Ohio Emergency Management Agency

    The following worksheet will show you how preparedness planning links to response. Take a few minutes to complete it. After you have done so, check it to make sure you have not omitted an important resource. Later, you may want...